Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Further Developments
End Session and View Feedback
  • Order a cappuccino and a kanelbulle anyway [undo]
  • Validate the emotion [undo]
  • A 70 years old male with hematuria [undo]
  • Χρησιμοποιώ μόνο Μεντελική πιθανότητα [undo]
  • Calcium: Increased; Potassium: Decreased; Sodium: Decreased [undo]
  • Semaglutide [undo]
  • Delay wound assessment until an in-person visit [undo]
  • State that assessment cannot continue without a clear image [undo]
  • Ask the patient to walk or change position (risk of falling). [undo]
  • Ask the patient to take a clear photo of the wound (10–15 cm distance, adequate lighting) and upload it to the app [undo]
  • Dapagliflozin [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21125
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Blame the patient for non-adherence
  • Order a cappuccino and a kanelbulle anyway
  • Validate the emotion
  • A 70 years old male with hematuria
  • Χρησιμοποιώ μόνο Μεντελική πιθανότητα
  • Calcium: Increased; Potassium: Decreased; Sodium: Decreased
  • Semaglutide
  • Delay wound assessment until an in-person visit
  • State that assessment cannot continue without a clear image
  • Ask the patient to walk or change position (risk of falling).
  • Ask the patient to take a clear photo of the wound (10–15 cm distance, adequate lighting) and upload it to the app
  • Dapagliflozin
  • Sitagliptin

Reminder

empty_reminder_msg

FINISH

Time is up